The 89Zr-DFO-Atezolizumab specificity binding studies showed a correlation between the cell-associated radioactivity and level of PD-L1 expression in human and murine GBM cells as seen by flow cytometry (Figure 1D). This evidence concerns the gene CD274 and glioblastoma.